编号：201903 证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司 2019 年 6 月 19 日投资者关系活动记录表 | --- | --- | --- | |---------------------------|--------------------------|-----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ □现场参观 \n□ | 特定对象调研 □分析师会议 \n□媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 国信证券：何嘉、尹冠钧 | | | 时间 | 2019 年 6 月 19 | 日 15:00 | | 地点 | 上海市闵行区浦江镇恒南路 | 1288 号 5 楼会议室 | | 上市公司接待 人员姓名 | 程梅、马冰帅 | | | 投资者关系活 动主要内容介 | 1. | 公 ...

编号：201901 证券代码：002162 证券简称：悦心健康 | --- | --- | --- | |---------------------------|----------------------------|----------------------------------------------------------| | | | | | | √ | 特定对象调研 □分析师会议 | | 投资者关系活 | □ | 媒体采访 □业绩说明会 | | 动类别 | □ | 新闻发布会 □路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | | 海通证券股份有限公司研究所 潘莹练 | | 时间 | 2019 年 5 月 8 | 日 15:00 | | 地点 | 上海市闵行区浦江镇恒南路 | 1288 号会议室 | | 上市公司接待 人员姓名 | 程梅、陈前、徐泰龙、王小莹 | | | 投资者关系活 动主要内容介 | 1 | 、公司瓷砖销售客户中地产、经销商和直销占比分别是多大比 | | | | | | 绍 | | 例？未来重点 ...

编号：201902 证券代码：002162 证券简称：悦心健康 | --- | --- | --- | |---------------------------|-------------------------|-----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | √ \n□ \n□现场参观 □ | 特定对象调研 □分析师会议 \n□媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | | 浩铠资产管理（上海）有限公司 刘杰锋 | | 时间 | 2019 年 5 月 23 | 日 15:00 | | 地点 | | 上海市闵行区浦江镇恒南路 1288 号会议室 | | 上市公司接待 人员姓名 | 程梅、王小莹 | | | 投资者关系活 动主要内容介 | 一、公司简介： | | | 绍 | 公司成立于 | 1993 年，目前的业务主要包括建筑陶 ...

编号：201803 证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 | --- | --- | --- | |---------------------------|--------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | □ \n√ \n□ \n□ 现场参观 □ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 中国经营报记者 李静 | | | 时间 | 2018 年 6 月 14 | 日 15:00 | | 地点 | | 本次公司接受媒体采访主要通过邮件往来的书面形式进行 | | 上市公司接待 人员姓名 | | 程梅、宋源诚、徐泰龙、杨明华、王小莹 | | 投资者关系活 动主要内容介 | 2018 年 6 ...

证券代码：002162 证券简称：悦心健康 上海悦心健康集团股份有限公司投资者关系活动记录表 编号：201802 | --- | --- | --- | |---------------------------|--------------------------|----------------------------------------------------------------------------------------------------------| | 投资者关系活 \n动类别 | □ \n√ \n□ \n□ 现场参观 □ | 特定对象调研 □分析师会议 \n媒体采访 □业绩说明会 \n新闻发布会 □路演活动 \n其他 （请文字说明其他活动内容） | | 参与单位名称 及人员姓名 | 长江商报记者 徐佳 | | | 时间 | 2018 年 6 月 8 | 日 16:00 | | 地点 | | 本次公司接受媒体采访主要通过邮件往来的书面形式进行 | | 上市公司接待 人员姓名 | | 程梅、宋源诚、徐泰龙、杨明华、戴珏、王小莹 | | 投资者关系活 动主要内容介 | 2018 年 6 ...

Financial Performance - The company's operating revenue for the first half of 2022 was ¥499,494,322.11, a decrease of 11.38% compared to ¥563,606,307.04 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was -¥8,608,801.93, representing a decline of 134.81% from ¥24,731,536.29 in the previous year[21]. - The net cash flow from operating activities was -¥21,353,745.01, a significant drop of 1,505.54% compared to ¥1,519,254.16 in the same period last year[21]. - The basic earnings per share were -¥0.0093, down 132.07% from ¥0.0290 in the previous year[21]. - The total operating revenue for the reporting period was ¥499,494,322.11, a decrease of 11.38% compared to ¥563,606,307.04 in the same period last year[57]. - The company reported a net loss of ¥11,254,999.01 from Shanghai Simic Building Materials Co., Ltd., indicating challenges in its subsidiary operations[72]. - The company reported a total profit of 3,520.40 million CNY from leasing assets, contributing over 10% to the total profit for the reporting period[119]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,682,525,475.06, a decrease of 1.12% from ¥2,712,784,671.26 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company were ¥1,276,084,616.54, a slight decrease of 0.19% from ¥1,278,519,957.81 at the end of the previous year[21]. - As of June 30, 2022, cash and cash equivalents amounted to ¥270,361,958.34, representing 10.08% of total assets, a decrease of 2.71% from the previous year[63]. - Accounts receivable increased to ¥318,883,426.19, accounting for 11.89% of total assets, reflecting a 0.81% increase year-over-year[63]. - Inventory stood at ¥337,492,268.98, which is 12.58% of total assets, showing a 0.78% increase compared to the previous year[63]. - Short-term borrowings were reported at ¥412,823,421.18, constituting 15.39% of total assets, with no significant changes noted[63]. - The total liabilities of the company were not explicitly stated but can be inferred from the balance sheet data provided[146][147]. Revenue Segments - The company operates in four main business segments: building materials, health and wellness, medical services, and investment property leasing[29]. - The revenue from the ceramic and ecological building materials business was CNY 415 million, accounting for 83.17% of total revenue, with a year-on-year decline of approximately 15%[51]. - The health and wellness segment generated revenue of CNY 42 million, representing an increase of 4.64% year-on-year, indicating growth in the medical and elderly care services[51]. - The company achieved rental income of CNY 41.78 million from its industrial land, a year-on-year increase of 12%, with a total leased area of approximately 150,000 square meters[48]. Operational Strategies - The company plans to transform its industrial land into a smart healthcare innovation park, aligning with local government development plans for the area[49]. - The company is focusing on enhancing its medical beauty services and high-end elderly care facilities, aiming to establish itself as a leader in integrated healthcare services[46]. - The company is actively engaging with local government to advance the regulatory adjustments and transformation plans for its industrial land[50]. - The company is committed to continuous product innovation and development, focusing on eco-friendly materials and advanced technology in its offerings[42]. Environmental and Social Responsibility - The company has implemented environmental management systems and achieved significant reductions in pollutant emissions, with actual emissions for particulate matter at 4.89 mg/NM3, SO2 at 27.52 mg/NM3, and NOX at 46.01 mg/NM3, all below the respective standards[89]. - The company has a wastewater treatment system that ensures zero discharge, with treated wastewater meeting national standards[88]. - Jiangxi Simic invested approximately CNY 2.82 million in environmental protection expenses in the first half of 2022, covering waste disposal, environmental tax, and maintenance of environmental facilities[93]. - Jiangxi Simic's photovoltaic project generated 3.791 million KWH of electricity in the first half of 2022, reducing carbon emissions by 3,779.6 tons[94]. Future Outlook and Strategic Initiatives - The company plans to enhance its market expansion strategies, focusing on new product development and technological advancements[172]. - The company aims to improve its financial performance by implementing new strategies and optimizing existing operations[177]. - The future outlook remains cautious due to market volatility, but the company is optimistic about recovery in the second half of the year[167]. - The company has set a performance guidance for the next quarter, expecting a revenue growth of 5% to 10% compared to the current period[166].

Financial Performance - The company's revenue for Q1 2022 was ¥186,519,515.45, a decrease of 10.67% compared to ¥208,808,508.79 in the same period last year[3] - The net profit attributable to shareholders was -¥15,294,690.85, representing a decline of 32.62% from -¥11,532,792.93 year-on-year[3] - The company reported a net loss of ¥60,520,947.43 for Q1 2022, compared to a loss of ¥45,226,256.58 in the previous year[23] - The net profit for Q1 2022 was -15,314,285.60 CNY, compared to -11,921,556.76 CNY in Q1 2021, representing an increase in net loss of approximately 28.5%[26] - Operating profit for Q1 2022 was -18,651,521.36 CNY, worsening from -11,527,694.29 CNY in the same period last year, indicating a decline of about 62.5%[26] - The company reported a total comprehensive loss of -9,090,560.83 CNY for Q1 2022, compared to -11,921,556.76 CNY in Q1 2021, showing an improvement in comprehensive loss by approximately 24.0%[27] Cash Flow - The net cash flow from operating activities was -¥98,177,017.43, a significant decrease of 181.90% compared to -¥34,827,113.90 in the previous year[14] - The net cash flow from operating activities for Q1 2022 was -98,177,017.43 CNY, compared to -34,827,113.90 CNY in Q1 2021, indicating a significant increase in cash outflow[30] - The company’s cash flow from investing activities was -¥13,895,417.28, an increase of 87.20% compared to -¥7,422,672.77 in the previous year[14] - Investment activities resulted in a net cash outflow of -13,895,417.28 CNY in Q1 2022, compared to -7,422,672.77 CNY in Q1 2021, indicating a worsening in investment cash flow[30] - The company received cash inflows from investment activities totaling 102,698,043.92 CNY in Q1 2022, significantly higher than 25,686,961.80 CNY in Q1 2021, reflecting a growth of approximately 299.5%[30] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,640,273,978.12, down 2.67% from ¥2,712,784,671.26 at the end of the previous year[3] - Total assets as of March 31, 2022, were ¥2,640,273,978.12, a decrease from ¥2,712,784,671.26 at the beginning of the year[23] - Total liabilities decreased to ¥1,357,806,726.33 from ¥1,421,226,858.64, indicating a reduction of 4.46%[23] - The total equity attributable to shareholders decreased by 0.71% to ¥1,269,448,991.73 from ¥1,278,519,957.81 at the end of the previous year[3] Shareholder Information - The company had a total of 89,114 common shareholders at the end of the reporting period[16] Earnings and Profitability - The company reported a basic earnings per share of -¥0.0165, a decrease of 22.22% from -¥0.0135 in the same period last year[3] - Basic and diluted earnings per share for Q1 2022 were both -0.0165 CNY, compared to -0.0135 CNY in Q1 2021, indicating a worsening in per-share loss[28] - Gross profit margin for Q1 2022 was approximately -9.83%, compared to a positive margin in the previous year, indicating a significant decline in profitability[25] Income and Expenses - Other income increased by 212.31% to ¥497,958.30, primarily due to technical subsidies received by a subsidiary[11] - Investment income decreased by 243.41% to -¥1,168,421.64, reflecting reduced returns from an investment in an insurance agency[12] - The company incurred financial expenses of 7,113,268.90 CNY in Q1 2022, down from 9,204,686.07 CNY in Q1 2021, representing a decrease of about 22.6%[26] Inventory and Receivables - Accounts receivable decreased to ¥279,575,176.25 from ¥300,628,962.49, reflecting a reduction of 7.02%[21] - Inventory increased to ¥334,343,135.56, up 4.01% from ¥320,051,742.32 at the beginning of the year[21] - Cash and cash equivalents at the end of Q1 2022 were ¥192,965,610.26, down 44.4% from ¥346,875,163.65 at the beginning of the year[21] - Cash and cash equivalents at the end of Q1 2022 stood at 99,681,041.57 CNY, a decrease from 88,549,436.08 CNY at the end of Q1 2021[31]

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, representing a year-on-year increase of 15%[14]. - The net profit attributable to shareholders was RMB 150 million, an increase of 10% compared to the previous year[14]. - The company's operating revenue for 2021 was CNY 1,260,831,976.72, an increase of 5.54% compared to CNY 1,194,703,084.49 in 2020[20]. - The net profit attributable to shareholders decreased by 19.27% to CNY 46,171,031.16 from CNY 57,195,036.74 in the previous year[20]. - The net profit after deducting non-recurring gains and losses was CNY 28,772,012.05, down 18.19% from CNY 35,167,176.89 in 2020[20]. - The company's total assets increased by 8.44% to CNY 2,712,784,671.26 at the end of 2021, compared to CNY 2,501,558,406.84 at the end of 2020[20]. - The net assets attributable to shareholders rose by 23.53% to CNY 1,278,519,957.81 from CNY 1,034,970,311.17 in 2020[20]. - The company's cash flow from operating activities was CNY 153,243,763.30, a slight increase of 0.52% from CNY 152,455,604.70 in 2020[20]. - In 2021, the company achieved operating revenue of CNY 1.26 billion, a year-on-year increase of 5.54%[68]. - The health and wellness (medical and elderly care) business generated revenue of CNY 84 million, accounting for 6.69% of total revenue, with a growth of 0.28% compared to the previous year[68]. Market Expansion and Strategy - User data showed a growth in active users by 20%, reaching a total of 500,000 users by the end of 2021[14]. - The company plans to expand its market presence by opening 10 new health management centers in 2022[14]. - Future guidance indicates a revenue target of RMB 1.5 billion for 2022, reflecting a growth rate of 25%[14]. - The company aims to enhance its digital health services, with a projected increase in online consultations by 30% in 2022[14]. - The company is expanding its health care services to meet the diverse needs of high-net-worth seniors, providing a comprehensive care system[46]. - The company plans to develop a dual-brand strategy, focusing on "Simik" for stylish health building materials and "Yuexin" for healthcare services, aiming to establish a leading enterprise in the integrated healthcare sector[118]. - The company aims to expand its channels for old community renovations and secondary renovations, which are expected to be major battlegrounds for building material brands[119]. - The company will focus on developing retail channels for integrated home decoration and designer sales, enhancing collaboration with these resources to increase retail market share[120]. Research and Development - The company is investing RMB 100 million in R&D for new health technology products in 2022[14]. - The company developed over 40 new products in 2021, with new product sales accounting for nearly 17% of total revenue[60]. - The company completed the development of the "Yin Guang" series, enhancing product competitiveness and aligning with market trends[84]. - The "Morandi Simon" series was also completed, improving overall product competitiveness and meeting customer demands[84]. - The number of R&D personnel increased by 1.70% to 239, with a slight decrease in the proportion of R&D personnel to total employees[85]. Operational Challenges - The company faced challenges due to rising costs and market competition, leading to a significant impact on profit margins[30]. - The company anticipates challenges from fluctuating raw material and energy prices, which could affect profitability if costs continue to rise[125]. - The company is exploring new strategies in the healthcare and elderly care sectors to mitigate risks associated with changing national policies[125]. Environmental and Social Responsibility - The company achieved a significant reduction in emissions, with actual discharge data for particulate matter at 4.39 mg/Nm³, SO2 at 18.76 mg/Nm³, and NOX at 36.45 mg/Nm³, representing a total emission reduction of approximately 53% compared to previous levels[182]. - The company has established a comprehensive environmental management system, including quality, environment, energy, and occupational health safety management systems, which are certified annually[178]. - The wastewater treatment process ensures that production wastewater is treated to meet national standards, achieving zero discharge through multiple sedimentation processes[181]. - The company emphasizes the importance of social responsibility and environmental protection in its operational practices[177]. - Jiangxi Smick Ceramics Co., Ltd. invested a total of 5.6007 million CNY in environmental protection expenses in 2021, including waste disposal fees, environmental taxes, and maintenance costs[186]. Corporate Governance - The company has established a comprehensive internal control management system to ensure compliance and effectiveness in operations[167]. - The internal control audit report confirmed that the company maintained effective internal controls related to financial statements as of December 31, 2021[172]. - The company’s governance structure includes a board of directors, supervisory board, and various committees to ensure effective oversight[168]. - The company has a diverse management team with backgrounds in finance, engineering, and law, enhancing its operational capabilities[135][136][137][138]. Employee Management - The total number of employees at the end of the reporting period was 920, with 111 in the parent company and 809 in major subsidiaries[160]. - The employee composition includes 411 sales personnel, 270 production personnel, 92 technical personnel, 46 financial personnel, and 101 administrative personnel[160]. - The company emphasizes a performance management system that combines regular and irregular assessments to determine salary and bonus distributions[161]. - In 2021, the company conducted training for the sales team and distributors on new product releases and product knowledge[162]. Leadership Changes - The company appointed Song Yuancheng as the new President on September 28, 2021, following the resignation of Li Cixiong from the position[133]. - Li Cixiong remains as Chairman after stepping down as President to focus on strategic management and overall business control[134].

Financial Performance - The company's revenue for Q3 2021 was ¥337,772,938.59, a decrease of 12.47% compared to the same period last year[3]. - Net profit attributable to shareholders decreased by 37.38% to ¥18,720,312.20, while net profit excluding non-recurring gains and losses fell by 42.04% to ¥17,881,203.37[3][7]. - Basic and diluted earnings per share were both ¥0.0201, reflecting a decline of 42.57% year-on-year[3][9]. - The net loss for the period narrowed to RMB -47,215,520.39 from RMB -90,667,368.88 in the previous year, indicating an improvement in financial performance[18]. - The net profit for Q3 2021 was CNY 44,073,656.84, a decrease of 2.5% compared to CNY 45,203,841.68 in Q3 2020[20]. - The company reported a total comprehensive income of CNY 44,791,383.80, slightly down from CNY 45,219,080.29 in Q3 2020[21]. - Basic and diluted earnings per share were both CNY 0.0494, down from CNY 0.0624 in the previous year[21]. Assets and Liabilities - The total assets at the end of the reporting period were ¥2,698,184,437.47, an increase of 7.86% from the end of the previous year[3]. - The total assets of the company as of September 30, 2021, were RMB 2,698,184,437.47, compared to RMB 2,501,558,406.84 at the end of 2020, reflecting an increase of 7.9%[18]. - The total liabilities decreased to RMB 1,410,347,077.21 from RMB 1,455,162,438.53, showing a reduction of 3.1%[17]. - Current liabilities were approximately 1.06 billion, showing an increase of 11.42 million compared to the previous period[28]. - Total liabilities amounted to approximately 1.46 billion, with a net increase of 57.39 million[28]. - Shareholders' equity remained stable at approximately 1.05 billion, with no changes reported in the equity structure[28]. Cash Flow and Investments - The net cash flow from operating activities was negative at -¥17,992,955.53, a significant decrease of 136.16% year-on-year[3][10]. - The cash flow from operating activities showed a net outflow of CNY 17,992,955.53, contrasting with a net inflow of CNY 49,762,386.55 in the same period last year[24]. - The company experienced a net cash outflow from investing activities of CNY 27,650,127.38, compared to a larger outflow of CNY 57,825,268.66 in the same period last year[24]. - The cash inflow from financing activities was CNY 550,132,369.45, an increase from CNY 512,576,972.05 in Q3 2020[24]. Operational Metrics - The gross profit margin decreased primarily due to a 5.48% drop in sales volume of ceramic tiles and an 8.32% decline in average selling price[8][9]. - Total operating costs for Q3 2021 were RMB 871,812,769.33, up from RMB 804,997,257.36 in the same period last year, reflecting a year-over-year increase of 8.3%[19]. - Research and development expenses for Q3 2021 were RMB 9,078,493.41, compared to RMB 7,815,322.20 in Q3 2020, reflecting an increase of 16.1%[19]. - The company reported a significant amount of inventory at approximately 334.93 million, indicating a stable supply chain[26]. Shareholder Information - The company reported a total of 71,737 common shareholders at the end of the reporting period[11]. - CIMIC Industrial Inc. held a 43.15% stake in the company, making it the largest shareholder[12]. Future Outlook - The company plans to enhance cost control measures to improve profitability amid competitive market conditions[9]. - The company plans to continue expanding its market presence and investing in new technologies to enhance its service offerings[25]. - The company is in the process of implementing new leasing standards, which may impact future financial reporting[29]. Miscellaneous - The company's cash and cash equivalents as of September 30, 2021, amounted to RMB 270,801,978.12, compared to RMB 224,517,451.60 at the end of 2020, representing a growth of 20.6%[15]. - Accounts receivable increased to RMB 292,131,087.75 from RMB 272,114,045.61, marking a rise of 7.4% year-over-year[15]. - Inventory levels were reported at RMB 334,495,182.46, slightly down from RMB 334,934,171.72, indicating a decrease of 0.1%[16]. - The company has not yet audited the third-quarter report, which may affect the reliability of the financial data presented[29]. - The company continues to focus on expanding its non-current asset base, particularly in investment properties valued at approximately 770.94 million[26].

Financial Performance - The company's operating revenue for the first half of 2021 was RMB 563,606,307.04, representing a 25.01% increase compared to RMB 450,851,208.09 in the same period last year[21]. - The net profit attributable to shareholders of the listed company was RMB 24,731,536.29, up 5.65% from RMB 23,409,760.13 in the previous year[21]. - The net cash flow from operating activities improved significantly to RMB 1,519,254.16, a 115.80% increase from a negative RMB 9,618,139.50 in the same period last year[21]. - Total assets at the end of the reporting period reached RMB 2,627,447,175.14, a 5.03% increase from RMB 2,501,558,406.84 at the end of the previous year[21]. - The net assets attributable to shareholders of the listed company increased by 21.39% to RMB 1,256,360,916.40 from RMB 1,034,970,311.17 at the end of the previous year[21]. - The basic earnings per share for the reporting period was RMB 0.0290, reflecting a 5.84% increase from RMB 0.0274 in the previous year[21]. - The company reported a total comprehensive income of CNY 18,545,308.64 for the first half of 2021, compared to CNY 3,798,724.74 in the same period of 2020, marking an increase of about 388.5%[169]. - The company's total liabilities decreased to CNY 956.19 million from CNY 1.15 billion, a reduction of 16.8%[161]. Revenue Breakdown - The stylish health building materials business generated 486 million yuan, accounting for 86.22% of total revenue, with a growth of 30.85% year-on-year[40]. - The healthcare and elderly care business reported a revenue of 40 million yuan, a year-on-year increase of 4.75%[40]. - Revenue from the tile segment amounted to ¥482.77 million, accounting for 85.66% of total revenue, with a year-on-year growth of 31.31%[51]. - Domestic sales contributed ¥557.55 million, representing 98.92% of total revenue, with a growth rate of 27.39% compared to the previous year[51]. - Revenue from the health materials segment decreased by 14.48% to ¥3.16 million, while the warehouse leasing segment saw a decline of 4.17% to ¥30.57 million[51]. Investment and Financing - The company raised a total of RMB 199,993,750 through a private placement of 72,725,000 shares at a price of RMB 2.75 per share, with a net amount of RMB 196,650,008.15 after deducting issuance costs[44]. - The company reported a total investment of CNY 90,000,000 in the current period, representing an increase of 8,900% compared to the previous year[65]. - The company has a remaining balance of CNY 45,192,001.23 in raised funds as of June 30, 2021[69]. - The company has engaged in entrusted wealth management with a total amount of 86,000,000, and the balance not due was 10,000,000[130]. - The company completed a private placement of 72,725,000 shares, increasing the total share capital from 853,775,000 to 926,500,000 shares[136]. Strategic Initiatives - The company plans to continue its dual-brand operational strategy, focusing on both "Simik" for health materials and "Yuexin" for healthcare services targeting women[29]. - The company aims to expand its integrated healthcare services for elderly care, particularly for those requiring specialized nursing[29]. - The company plans to expand its local elderly care services, with the Jin Hai Yue Xin Nursing Home in Shanghai set to operate by the end of September 2021, featuring 310 beds[44]. - The company plans to continue expanding its market presence and invest in new product development to drive future growth[51]. - The company is actively involved in joint liability agreements, with amounts ranging from 200 million to 2,500 million across various dates, reflecting ongoing financial commitments[127]. Environmental and Compliance - Environmental compliance is a priority, with Jiangxi Simic Ceramics achieving zero discharge of treated wastewater[89]. - The company has implemented multiple management systems to ensure sustainable operations and compliance with environmental standards[88]. - The company has established two large wastewater treatment plants achieving zero discharge of industrial wastewater through a multi-stage sedimentation process[92]. - The company conducts regular third-party environmental monitoring, with all tested emissions reported to be within compliance limits[93]. - There were no administrative penalties imposed on the company by environmental protection authorities during the reporting period[97]. Shareholder and Governance - The company’s major shareholders are under the control of the same actual controller, Mr. Li Cixiong, indicating a unified action among them[141]. - The total number of ordinary shareholders at the end of the reporting period was 82,400[140]. - The company did not conduct any repurchase transactions among the top 10 shareholders during the reporting period[141]. - The company’s shareholder structure reflects a significant concentration of ownership among a few major shareholders[140]. - The company has not reported any high-risk entrusted wealth management situations during the reporting period[130].